Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
life sciences
national blog main
san francisco blog main
5
×
boston top stories
clinical trials
fda
national top stories
new york blog main
san diego blog main
boston
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
gene therapy
indiana blog main
indiana top stories
investing
ipo
loxo oncology
messenger rna
national
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego top stories
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2025
ad-comm
affimed
akcea therapeutics
What
ipo
5
×
therapeutics
5
×
drug
medicines
new
biotechs
cancer
companies
million
affects
ago
allogene
americans
approved
bio
biotech
black
clinic
club
considering
continued
crispr
crop
data
date
developing
diamond
diseases
diversity
dyne
early
eluded
exceeded
expected
experimental
eyes
fda
firms
frequency
genetic
Language
unset
Current search:
ipo
×
therapeutics
×
" san francisco blog main "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Frequency Plans IPO for Hearing Loss Drug & More Regenerative Meds
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M